Tacrolimus eye drops for severe eye allergy in children
Part of Eyes & vision, Immune system & allergy clinical trials.
This trial tests if tacrolimus eye drops can safely treat severe eye allergies (vernal keratoconjunctivitis) in children ages 5 to 15. It aims to reduce symptoms like itching, redness, and discomfort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 5 and 15 years old
- You must have moderate to severe active eye allergy (vernal keratoconjunctivitis)
- You cannot have any other eye infections or diseases
- You cannot use contact lenses
- You cannot be taking medications that weaken the immune system
- You cannot have a history of herpes eye infections or recent eye surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new eye drop called diquafosol for people with a severe, active eye allergy called vernal keratoconjunctivitis. It aims to see if the drops can calm the allergy and help heal the surface of the eye.
This trial tests a new eye drop (tacrolimus) to treat non-infectious anterior uveitis, an inflammation in the front part of the eye. It may help reduce the need for steroid eye drops.
This study tests a new eye drop (T1695) against cyclosporine for children with moderate to severe vernal keratoconjunctivitis, a type of eye allergy. It aims to see which treatment works better and is safer for reducing symptoms.
This trial tests whether taking oral probiotics can improve eye symptoms and gut health in children with vernal keratoconjunctivitis, a severe type of eye allergy. It is for children aged 4 to 18 who haven't recently used certain medications or supplements.
This trial tests whether crisaborole ointment works as well as tacrolimus ointment for children ages 2 to 18 with mild to moderate atopic dermatitis (eczema). If your child has eczema covering less than 30% of their body and hasn't used certain creams or medications recently, this study may be an option.
This study tests whether a clobetasol steroid eye drop (a nanoemulsion) reduces eye inflammation after cataract surgery in babies and toddlers. It may help protect comfort and eye healing after surgery.
Hear when a new Vernal Keratoconjunctivitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.